We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$288B
AUM Growth
+$15.1B
Cap. Flow
-$7.18B
Cap. Flow %
-2.5%
Top 10 Hldgs %
29.46%
Holding
5,511
New
303
Increased
1,218
Reduced
2,942
Closed
472

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.11B
2
AMZN icon
Amazon
AMZN
+$1.13B
3
MSFT icon
Microsoft
MSFT
+$972M
4
NVDA icon
NVIDIA
NVDA
+$894M
5
INTC icon
Intel
INTC
+$766M

Sector Composition

Rank Sector Weight
1 Technology 24.17%
2 Financials 9.79%
3 Consumer Discretionary 8.06%
4 Healthcare 7.69%
5 Communication Services 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAU
5276
DELISTED
Almaden Minerals Ltd
AAU
-500
Closed -$73
PGTI
5277
DELISTED
PGT, Inc.
PGTI
-270,787
Closed -$11M
CBAY
5278
CALL
DELISTED
Cymabay Therapeutics
CBAY
-30,000
Closed -$709K
CBAY
5279
DELISTED
Cymabay Therapeutics
CBAY
-190,332
Closed -$4.5M
CBAY
5280
PUT
DELISTED
Cymabay Therapeutics
CBAY
-30,000
Closed -$709K
HCMAW
5281
DELISTED
HCM Acquisition Corp Warrant
HCMAW
-375,000
Closed -$10.1K
AYX
5282
CALL
DELISTED
Alteryx Inc
AYX
-3,500
Closed -$165K
AYX
5283
DELISTED
Alteryx Inc
AYX
-311,994
Closed -$14.7M
AYX
5284
PUT
DELISTED
Alteryx Inc
AYX
-113,500
Closed -$5.35M
BCEL
5285
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-47,487
Closed -$6.27K
KRTX
5286
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-18,000
Closed -$5.7M
KRTX
5287
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-82,074
Closed -$26M
KRTX
5288
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-18,000
Closed -$5.7M
SPLK
5289
CALL
DELISTED
Splunk Inc
SPLK
-5,500
Closed -$838K
SPLK
5290
DELISTED
Splunk Inc
SPLK
-1,381,364
Closed -$210M
SPLK
5291
PUT
DELISTED
Splunk Inc
SPLK
-48,000
Closed -$7.31M
DBGR
5292
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
-1,000
Closed -$32.1K
SOVO
5293
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-261,167
Closed -$5.75M
EACPW
5294
DELISTED
Edify Acquisition Corp. Warrant
EACPW
-14,000
Closed -$202
AMAM
5295
DELISTED
Ambrx Biopharma Inc
AMAM
-199,950
Closed -$2.85M
LBC
5296
DELISTED
Luther Burbank Corporation Common Stock
LBC
-34,288
Closed -$367K
CRGE
5297
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$0 ﹤0.01%
1
-186,994
-100% -$21.4K
ROVR
5298
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-320,924
Closed -$3.49M
RYZB
5299
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-35,016
Closed -$2.18M
SLACW
5300
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
-520
Closed -$5.43K

Similar funds

Barclays's Q1 2024 Portfolio in Review

As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
  • Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
  • Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
  • Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
  • Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
  • Barclays opened 303 new positions and closed 472 in Q1 2024.
  • Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.